Versuchen GOLD - Frei

When can India become a global gateway for the medtech industry?

Bio Spectrum

|

BioSpectrum Indian Feb 2025

Over 70 per cent of innovations by Indian medical technology startups are powered by digital integration, driven by a convergence of factors accelerating the industry's growth, according to a recent report by EY. Additionally, government initiatives are playing a pivotal role in positioning India as a global medtech hub. And the growing US FDA approvals is providing the required recognition to Indian medical technologies. Would these developments eventually lead to import independence for the Indian medtech sector?

- Vrushti Kothari

When can India become a global gateway for the medtech industry?

The Indian medtech market, valued at $12 billion in 2023-24, is projected to reach $50 billion by 2030, with India's global market share set to grow from 1.65 per cent to 10-12 per cent over the next 25 years. Further, Indian medtech exports reached $3.8 billion in 2023-24, with the US as the primary market. Although India is still import dependent in the medtech sector, the growing number of startups in this space are moving the tailwinds in a global direction.

Over the past few years, medtech startups have emerged as trailblazers, using innovation to bridge gaps, solve pressing challenges, and unlocking new possibilities in healthcare. This growth is particularly crucial in India, where healthcare challenges include vast geographical disparities, increasing disease burdens, and affordability constraints.

For example, artificial intelligence (AI)-driven diagnostic solutions are helping healthcare providers detect diseases at earlier stages, while wearable devices are empowering individuals to monitor their health in real time. As a result, Indian medtech startups are actively integrating digital solutions such as AI, IoT, and cloud computing to democratise healthcare with portable devices, remote monitoring and screening tools. Taking a few examples, BrainSight AI, a Bengaluru-based deep-tech neuroscience startup, is revolutionising the diagnosis and treatment of complex brain disorders through its technology platform, VoxelBox. Likewise, another Bengalurubased startup 4baseCare is using advanced genomics and digital health technology to offer cutting-edge precision oncology solutions.

WEITERE GESCHICHTEN VON Bio Spectrum

Bio Spectrum

S&T Minister inaugurates Biotechnology Research and Innovation Council (BRIC) Secretariat

The Union Minister of (Independent State Charge) for Science and Technology (S&T) Dr Jitendra Singh recently inaugurated the Biotechnology Research and Innovation Council (BRIC) Secretariat by unveiling the inaugural curtain, marking the official opening of a new milestone in India's biotechnology journey.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

US announces $50 B in awards to strengthen rural healthcare

The Centers for Medicare & Medicaid Services (CMS) has announced that all 50 states will receive awards under the Rural Health Transformation Program, a $50 billion initiative established under President Trump's Working Families Tax Cuts legislation (Public Law 119-21) to strengthen and modernise healthcare in rural communities across the country.

time to read

1 min

February 2026

Bio Spectrum

WHO unveils Traditional Medicine Global Library

At the second WHO Global Summit on Traditional Medicine, jointly organised with the Government of India, concluding recently in New Delhi, WHO unveiled the Traditional Medicine (TM) Global Library (GL), a first-of-its-kind digital platform consolidating 1.6 million resources on TM, from scientific studies to indigenous knowledge.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Telangana sets global ambition with Life Sciences Policy 2026-30 targeting $25 B investments

The Government of Telangana unveiled its Next-Gen Life Sciences Policy 2026-30 at the World Economic Forum Annual Meeting in Davos, signalling the State's intent to play a far more consequential role in shaping the future of global healthcare, advanced therapeutics, and sustainable bio-manufacturing.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

WHO reveals major equity gaps in human genomics research

The World Health Organization (WHO) has published a new global analysis of human genomics in clinical research, covering more than three decades of studies registered between 1990 and 2024.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Biotium launches GlycoLiner Cell Surface Glycoprotein Labeling Kits

US-based Biotium, a leading innovator in fluorescent dyes and life science reagents, has announced the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Bruker consolidates ownership of TOFWERK in expansion of mass spectrometry portfolio

Bruker Corporation has announced the acquisition of an additional 60 per cent ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100 per cent.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

India & Australia develop precision nano-injection platform for breast cancer drug delivery

Researchers from the Indian Institute of Technology Madras (IIT-M), Monash University and Deakin University, Australia, have developed a cutting-edge nano-injection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.

time to read

1 min

February 2026

Bio Spectrum

Agilent opens India Refurbishment Centre in Manesar

Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, has announced the inauguration of its India Refurbishment Centre at its LEED Platinum-certified facility in Manesar, Haryana.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Yashoda Medicity appoints Dr Rajinder Kumar as Unit Head, Department of Neurosurgery

Yashoda Medicity, one of the leading hospitals in the Delhi NCR, has appointed Prof. Dr Rajinder Kumar as Principal Director & Unit Head, Neurosurgery at the Yashoda Institute of Neurosciences.

time to read

1 min

February 2026

Listen

Translate

Share

-
+

Change font size